Fever has for many years been suspected to harm the developing fetus. Starting in the 1960s, evidence on the teratogenic effects of hyperthermia began to accumulate from animal studies. 1, 2 Even short exposure to elevated maternal body temperature has been reported to lead to cell death, membrane disruptions, vascular disruptions, and placental infarction, all of which affect the risk of structural or functional defects in the offspring. 3, 4 Studies in animal models provide evidence that prenatal exposure to elevated body temperature, as a marker of maternal fever, leads to increased prevalence of various adverse health outcomes in the offspring. These outcomes encompass both structural and functional defects, and they range from growth retardation, malformations, and fetal death to longer-term outcomes such as behavioral alterations and impaired cognitive functioning. 4, 5 These findings have been consistent across a variety of animal species, including mice, rats, hamsters, guinea pigs, rabbits, sheep, pigs, and monkeys. 1 Despite the bulk of evidence supporting a link between exposure to maternal hyperthermia and adverse health outcomes in animal offspring, however, it remains unclear whether the experimental conditions under which these associations have been observed are applicable to conditions in which humans would naturally experience hyperthermia, and hence whether similar associations would be expected.
Maternal fever is common during pregnancy. In fact, ∼1 in 5 women report having experienced fever on at least 1 occasion while being pregnant. [6] [7] [8] Observational epidemiologic studies have consequently been conducted to assess potential effects of exposure to maternal fever on fetal development and child health. Given the high proportion of pregnant women who are exposed to fever, even a small increase in the risk of these outcomes would make maternal fever a public health concern. We identified 1 previous publication that reviewed the literature on the impact of hyperthermia on neural tube defects. 9 However, up until now, no systematic analysis has been undertaken to assess the impact of maternal fever on a broader spectrum of health outcomes in human offspring. Thus, the aim of the present article was to systematically review existing evidence from epidemiologic studies on the associations between maternal fever during pregnancy and adverse health outcomes in the child.
METHODS
The Preferred Reporting Items for Systematic Reviews and Meta-analyses statement 10 was used as a reporting guideline for this review.
Identification of Studies
To identify relevant studies for inclusion in the review, we applied a 2-stage search strategy. First, we systematically searched bibliographic databases (PubMed, Web of Science, and the Cochrane Library) by using Medical Subject Headings, Boolean operators, and truncation. We searched in titles, abstracts, topics, and key words depending on the database, and applied limits restricting the search to studies published in 1990 or later and to human studies. Search words included fever, febrile, hyperthermia, pyrexia, pregnancy, pregnant women, and gestation. Second, we used a snowballing technique, in which we pursued references of references, to detect reports of studies not found in the database search. Studies were initially identified based on title and abstract and later included through fulltext evaluation. The latest search was conducted in August 2013.
Study Eligibility
Cohort and case-control studies addressing health outcomes of prenatal fever exposure in humans were eligible for inclusioninthereview.Studieswereincluded only if they made direct references to fever; that is, by addressing fever directly or alternatively by addressing febrile illnesses as a proxy for fever. We excluded studies in selected populations (eg, studies addressing only preterm births) and studies in which the report was inadequate to thoroughly evaluate the methods and results. In addition, we chose to limit the review to more recent evidence, including only studies published since 1990 until August 2013. We excluded duplicate publications and studies with inadequate assessment of fever or those in which we could not distinguish prenatal fever exposure from fever in relation to labor. The criteria used to include and exclude studies in the review are illustrated in 
Data Extraction
Information on reference, publication date, design, study population, sample size, fever assessment, exposure period of interest, outcome considered, overall effect estimates, and estimates for varying fever intensities and for antipyretic use was extracted. Because several of the studies included a variety of analyses on fever exposure, we applied the following decision rules for extraction of effect estimates. First, whenever results in case-control studies were presented for .1 comparison group, we always chose estimates from comparisons with matched control subjects over general population control subjects, and general population control subjects over malformed control subjects. Second, when both crude and adjusted measures were available, we chose adjusted measures, with the exception of the studies that were included in meta-analyses. For these, crude measures were applied to ensure comparability of studies. Finally, if a study specified a certain exposure period of interest (eg, first-trimester exposure), we chose estimates pertaining to this time period.
Evidence Rating
The risk of bias of included studies was assessed by using the NewcastleOttawa Scale, 11 as recommended by Deeks et al. 12 Risk of bias in relation to selection, comparability, and assessment of the exposure/outcome was assessed according to 9 items by using a star allocation scheme. Stars were allocated if a study was deemed to have a low risk of bias within each item, according to the coding manual provided. 13 A study was categorized as being of low risk of bias if a total of 8 to 9 stars were allocated, medium risk of bias if 6 to 7 stars were allocated, and of high risk of bias if the study was given #5 stars.
Data Synthesis
To quantitatively combine results of studies addressing the same outcome, meta-analyses were performed by using Stata version 13 (Stata Corp, College Station, TX) 14 when $4 studies were eligible for inclusion. Statistical heterogeneity was assessed by using the Cochran' s x 2 statistic. When studies were homogeneous, we applied a Mantel-Haenszel fixed-effects model; the DerSimonian and Laird random effects model was used when studies were heterogeneous. Studies not suitable for inclusion in meta-analyses were presented in a table, according to the outcome of interest. No summary measures were calculated for these studies, however, as they were too heterogeneous in terms of methods and the outcomes addressed. Lastly, we summarized studies addressing the effects of temperature elevation as well as of antipyretic use.
RESULTS
Seventy-eight potentially eligible studies were identified through systematic searches in relevant databases or through reference reviews. Based on the full-text evaluation, 32 studies were excluded. The main reasons for exclusion were inadequate assessment or reporting of fever exposure, inadequate description of the study, and duplicate analyses across different publications. A total of 46 studies were included in the review.
The characteristics of included studies are summarized in Table 1 . 6, 7, Studies varied in size from ∼100 to 100 000 observations, and approximately onehalf of the reports were based on samples of $4000 observations. With 1 exception, 18 fever was measured as maternal self-reported episodes of fever or febrile illness, with or without specific subquestions concerning number of episodes, maximum temperature, duration of fever, accompanying symptoms or illness, timing of exposure, and use of antipyretic measures to treat the fever. The studies considered fever exposures from up to 3 months before conception through the entire pregnancy; however, the majority of the studies considered primarily first-trimester exposures. This choice was a reflection of the outcomes considered in the studies, as a large proportion of included studies addressed birth defects in which the critical developmental period is considered to be early in pregnancy. In general, the prospective cohort studies tended to be of lower risk of bias compared with case-control studies. Within case-control studies, the populationbased studies were generally classified with a lower risk of bias compared with the nonpopulation-based studies.
Fever and Health Effects in the Child
Associations between exposure to maternal fever and a variety of health outcomes were addressed in the included studies. A substantial proportion of studies considered shorter-term health effects, such as adverse pregnancy outcomes and birth defects, whereas a smaller proportion investigated the post-neonatal health effects, such as allergic diseases, developmental outcomes, and offspring mortality. Random effects meta-analyses were conducted for case-control studies on neural tube defects (n = 9) and oral clefts (n = 5), due to statistical heterogeneity, whereas a fixed-effects metaanalysis was conducted for studies on congenital heart defects (n = 7). All of the studies included in the meta-analyses were restricted to preconceptional and first-trimester fever exposure. 35, 48 showed only slightly lower pooled estimates, which remained statistically significant (data not shown).
Fewer studies were available for each remaining health outcome. The overall estimates of the impact of maternal fever exposure are presented in Table 2 for each study, ordered from short-to longer-term effects in the child. With 2 exceptions, 27,55 studies on pregnancy outcomes (ie, spontaneous abortion, stillbirth, preterm birth, birth weight) found no association with maternal fever exposure. For birth defects, conversely, several studies suggested that fever exposure is associated with excessive risk. Although Acs et al, 35 Zhang and Cai, 50 and Erickson 48 suggested that the risk of any birth defect is increased by ∼40% to 60% for those children exposed to maternal fever during the first trimester, Chambers et al 24 suggested an even higher, although not significant, risk for major malformations. Although these estimates may be driven by neural tube defects, congenital heart defects, and oral clefts, as suggested by the metaanalyses, associations were also reported for several other birth defects, including ear defects, 33 anorectal malformations, 52 renal defects, 43 cataract, 36 and limb deficiencies. 44 Other studies reported no significantly increased risk for several of the same outcomes. 24, 26, 35, 54 The evidence of an association with birth defects other than neural tube defects, congenital
FIGURE 2
Forest plot of case-control studies considering maternal fever and risk of neural tube defects in the offspring.
heart defects, and oral clefts is therefore limited, as most defects were only investigated in 1 or 2 populations, and results seemed to be inconsistent between the studies.
For allergic diseases, 2 studies report an approximately twofold increased risk of asthma in children exposed to maternal fever, 20,53 whereas another study found no association with wheezing, eczema, or atopic sensitization. 22 Significant longer-term effects on the child development of exposure to maternal fever were also reported, however, with estimates in general closer to unity. In 3 studies on childhood autism 16, 56 and autism spectrum disorders, 38 an increased risk was observed in relation to fever exposure. Increased risks were also reported for cerebral palsy, 15,49 developmental delay, 38 various behavior characteristics, 19 decreased academic performance, 19 and psychosis. 57 No overall association was reported for epilepsy 17 or schizophrenia, 21 however. In addition, 1 study 23 in women infected with varicella-zoster virus found no increased risk of neurobehavioral deficits after fever in relation to the infection. Lastly, 1 study considered overall mortality and found that maternal febrile episodes significantly increased the mortality rate in the offspring in male subjects but not in female subjects. 18 When we considered effect sizes reported across different health effects, we found that studies which were conducted prospectively were more likely to report lower risk estimates compared with studies with retrospective assessment of fever and also more likely to find no effects of fever. Likewise, studies with lower risk of bias were also more likely to report lower risk estimates compared with studies with higher risk of bias.
Risk in Relation to Level of Fever
Fever intensity, measured by the maximum temperature during a fever episode, was hypothesized in several studies to affect the strength of the association with the outcome of interest. Studies reporting estimates for different fever intensities are summarized in Table 3 . Chambers et al 24 reported nonsignificant increases in the risk of several minor birth defects with increasing intensity of fever. However, none of the remaining studies 7, 16, 17, 40, 41 reported such a temperature-response relationship.
Antipyretic Medication
Studies that investigated whether the use of antipyretic medication attenuated the risk related to maternal fever exposure are presented in Table 4 .
One study 30 reported that use of antipyretics was associated with an increased risk of the given outcome compared with the risk observed with fever alone. This tendency is supported by another study by Wang et al 29 (not presented in Table 4 ; relevant numbers were not reported). In contrast, several other studies observed reductions in risk with antipyretic medication. 34, 35, [38] [39] [40] 42, 46, 47 In some cases, the risk associated with fever was even eliminated. 35, 36 ,40
DISCUSSION
Our review shows that the available literature supports the occurrence of adverse health impacts in association with fever. The strongest evidence is available for effects on the following selected birth defects: neural tube defects, congenital heart defects, and oral clefts, in which pooled estimates suggest between a 1.5-and nearly 3-fold increased risk through exposure to maternal fever during the first trimester. Some, but not all, evidence furthermore supports an association with other birth defects, developmental deficits, and overall mortality. However, despite the numerous studies reporting associations between fever and adverse health outcomes, we found no strong evidence to suggest that these associations were subject to a doseresponse relationship. In addition, we found that most studies, but not all, suggested a protective effect of antipyretic medications when used in relation to febrile episodes. To our
FIGURE 4
Forest plot of case-control studies considering maternal fever and risk of oral clefts in the offspring. The table shows the effect of fever exposure on several outcomes, reported as ORs, relative risks (RRs), hazard ratios (HRs), or incidence rate ratios (IRRs). Whenever adjusted effects were available, these are reported with the prefix a.
a Estimates are calculated based on numbers from the original article.
b
Estimates from the original article reported odds of having better academic grade. To ensure comparability we reversed the estimate; therefore, the OR shows the risk of having a lower grade.
knowledge, this is the first review that systematically assesses and synthesizes studies on the entire spectrum of adverse health outcomes in the child after fever exposure during pregnancy.
Although there was evidence of an adverse impact of fever on several health outcomes, the strength of this evidence varied considerably. For neural tube defects, congenital heart defects, and oral clefts, several studies were available, enabling us to calculate pooled estimates based on meta-analyses. The findings of increased risks related to prenatal fever exposure remained statistically significant even when studies with a high risk of bias were excluded. For other birth defects, allergic diseases, and for developmental deficits, the evidence was limited due to fewer studies addressing each outcome, varying risk of bias, and a higher degree of inconsistency between study findings. The associations found in studies reporting an adverse effect of fever are nevertheless generally consistent with effects reported from animal studies. 1 One finding that did contrast with evidence from animal studies, however, was the fairly consistent suggestion that fever had no effect on the risk of adverse pregnancy outcomes (spontaneous abortion, stillbirth, and preterm delivery). It is unclear why no association was observed for these very short-term outcomes as these are some of the most frequently reported adverse outcomes in animal studies. 3 It may be that the extent of increased body temperature experienced by women during a fever is not sufficient to cause such severe harm that it leads to fetal death. Generally, it is suggested that maternal body core temperature can be raised by ∼2°C or more before risk of fetal death is increased. 2 This increase is equivalent to a fever of $39°C. However, both the study by Chambers et al 24 and that by Andersen et al 7 performed REVIEW ARTICLE subanalyses restricted to women with temperatures of $38.9°C, but the risk remained unchanged. Another explanation could be that prospective studies addressing adverse pregnancy outcomes, such as spontaneous abortion, did not recruit the pregnant women in time to catch most of the very early pregnancy losses and consequently found no overall effect.
In the reviewed studies, we also found little evidence to support a doseresponse relationship with temperature. This evidence was based on studies assessed to be of low and medium risk of bias. The absence of a dose-response relationship contrasts with findings from animal studies and also seems counterintuitive if a causal relationship between fever and adverse health outcomes exists. It could possibly be explained by the fact that the studies used self-reported measures of the maximum temperature during a febrile event, and such a measure is likely to be imprecise several weeks or even months after the episode occurred. Furthermore, thermal dose is not only defined by the elevation of temperature but also by the duration of the exposure. It might therefore be necessary to consider both temperature elevation and fever duration in combination when looking for a dose-response relationship. This theory is supported in the study by Chambers et al, 24 who defined a high fever group by using both temperature elevation and duration. This study was the only 1 of 6 reported in Table 3 that found a dose-response relationship for several minor birth defects. An increased risk by increasing duration of the fever alone (ie, without considering temperature elevation) was also reported by Atladóttir et al 16 and Suarez et al 42 but not by Sun et al 17 or Andersen et al. 7 On the basis of studies with varying risks of bias, we also found evidence to suggest that antipyretic use seemed to attenuate the risks associated with fever exposure. Only 2 of 10 studies reported increased risk associated with antipyretic use in relation to a febrile episode. 29, 30 Nevertheless, substantially more studies reported results suggesting that antipyretic use decreased the risk associated with fever exposure. Differences between study findings may be due to differences in the type of antipyretic agents commonly used, as this use can vary between countries. 30 The fact that a reduction or removal of the fever generally seems to decrease the risk of a given outcome supports the notion that fever itself carries a risk and, furthermore, that this risk is distinct from a potential risk associated with the infection causing the fever. It also provides the possibility of preventing occurrence of adverse health effects in the child, if fever is readily treated in pregnant women. Nevertheless, some antipyretic agents have also been suspected of having detrimental effects on the fetus, 59 and more research is needed to be able to identify safe choices of antipyretics and to estimate if potential risks of antipyretic use outweigh the benefits of reduced temperature. One potential concern about the studies investigating the effect of antipyretic use was that several studies did not specify whether the antipyretic medication was taken as a measure to treat fever. Most antipyretic medications have other purposes in addition to fever management, and it is possible that they were used as analgesics instead. If the antipyretics were generally used in relation to the underlying infection and not at the time of the fever, it would dilute the measure of effect. Only 3 studies 30, 38, 46 clearly stated that the antipyretics were taken as a measure to treat the fever; however, no systematic differences in effect estimates or SEs were seen between these and the remaining studies.
There are several mechanisms through which fever has been proposed to interfere with fetal development. When infection in pregnancy occurs, the maternal immune system is mobilized, causing changes in the level of cytokines in the fetal environment. Some cytokines, such as interleukin 1, interleukin 6, and tumor necrosis factora, are pyrogenic, causing hyperthermia to occur through alteration of the set point in the hypothalamus. 60 Hypothesized effects of the increased body temperature include interruption of protein synthesis and enzyme production, which results in cellular processes (eg, proliferation, migration, differentiation, apoptosis) becoming altered or dysfunctional. 4, 60 In addition, as a reaction to the fever, the heat shock response is induced. 2 The response acts as a survival mechanism, and the expression of heat shock proteins is increased to enhance cellular resistance to thermal stress. 60 The heat shock response takes precedence over other cellular activities, resulting in inhibition of protein synthesis and cell proliferation. 4 It is consequently believed that these mechanisms may disturb or harm the fetal development if they coincide with specific windows of vulnerability.
From animal studies, we know that different defects hold unique windows of vulnerability. Although some of the studies included in the review considered fever exposure in specific periods of the pregnancy, others considered the entire pregnancy. Detrimental effects of prenatal exposure to fever might be diluted if too-broad time intervals of exposure are used in the analyses. Czeizel et al 61 suggested that future research in this area should consider critical exposure periods as specific as possible to the outcome of interest and not rely only on commonly used indicators of time, such as trimesters. We found most evidence to support a harmful effect of fever in the early stages of pregnancy. The majority of the studies, however, also only considered these early exposures, which were related to their outcomes of interest (namely, birth defects). Whether exposure later in pregnancy is harmful was less studied. Both the studies by Dombrowski et al 19 and by Calvani et al, 53 however, suggest that exposures in middle and late pregnancy may lead to longer-term adverse effects in the child. Nevertheless, the current evidence is insufficient to conclude whether fever might be harmful in all stages of pregnancy.
It is well established that several infections, such as the TORCH complex (toxoplasmosis, other vertically transmitted infections, rubella, cytomegalovirus, herpes simplex virus 2), have teratogenic effects. 62, 63 In addition, a range of other infections (eg influenza, 64 Q fever, 65, 66 HIV 67 ) are suspected of having detrimental effects on the child. Because fever occurs as a response to infection, it is problematic to distinguish the effects of fever from those of an underlying infection and also from the potential treatment of the infection or the fever. These concerns should be kept in mind when interpreting the findings of the present review. However, because the aim was to summarize studies discussing prenatal exposure to fever as a potential threat to the child, we have not included studies on infections only. Instead, only studies with a direct reference to fever were considered. Consequently, we included studies that defined fever by using specific questions on fever but also whenever authors defined an infection as being a febrile illness. The concept of a febrile infection is only vaguely defined, however, and studies considered infections from influenza, in which ∼90% 35 experience fever, to infections such as the common cold, in which fever might only be present in ∼50% 68 of cases. If an infection in which fever only occurs in one-half of the cases is used as a proxy for fever, it would lead to substantial misclassification of the fever exposure. Because this misclassification is most likely unrelated to the outcomes, it would be unsystematic (nondifferential), suggesting that studies using febrile infections as a measure of fever would, in most cases, underestimate the impact of fever.
Another concern in systematic reviews is the potential for publication bias, and we cannot exclude the possibility that this factor could have affected the findings of this review. In addition, a number of studies were found to have a medium or high risk of bias, when assessed by using the NewcastleOttawa Scale. A general problem for a large proportion of the studies was the potential for bias in the assessment of fever. Several of the findings were based on case-control studies that have assessed fever exposure only after the presence or absence of the outcome was recognized. Compared with cohort studies, case-control studies are more prone to biases originating from differential recall for case and control mothers as well as from selection. We observed that, across different health outcomes, studies using a retrospective design were more likely to report higher risks compared with studies using a prospective design, which could suggest that pooled estimates from the meta-analyses, as well as individual results of case-control studies, were subject to positive bias. Several of the case-control studies did also try to overcome problems in relation to selection bias, by using a populationbased design, to ensure that control REVIEW ARTICLE subjects reflected the population that gave rise to the cases. Some studies also performed sensitivity analyses by using malformed control subjects to assess the extent of recall bias. Li et al, 30 Lynberg et al, 47 and Medveczky et al 37 found smaller effects when they used a malformed comparison group; however, the associations were always in the same direction and remained statistically significant.
CONCLUSIONS
We found substantial evidence to support an adverse impact of maternal fever during pregnancy. The harmful effects seemed to cover both some short-and longer-term health outcomes. With this review, we do not have adequate evidence, however, to rule out or confirm associations with many of the investigated outcomes. Prospective studies are therefore now required to investigate whether the findings from case-control studies on birth defects remain valid when the exposure to fever is assessed before the outcome occurs. Research on longer-term health impacts is also still in its infancy, but several of the studies included in the review indicate that this is a relevant area of further research. In addition, we suggest that further research aspires to clarify the impact of timing, duration, and extent of fever, as well as the potential role of antipyretic agents.
